Guangyu Wang

Assistant Professor

Houston Methodist
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (11)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

PURPOSE Cancer remains a leading cause of death worldwide. The growing volume of high-throughput single-cell and spatial transcriptomic data sets—particularly those related to cancer—offers immense opportunities as well as analytical challenges for effective data analysis and interpretation. Large language models (LLMs), pretrained on vast data sets and capable of various biomedical tasks, offer a promising solution. This review explores the application of LLMs in cancer research from both cellular and pathologic perspectives, aiming to showcase their potential in advancing precision oncology. MATERIALS AND METHODS We systematically review current LLMs in analyzing single-cell RNA sequencing, spatial transcriptomic, and histology image data, emphasizing their relevance to cancer biology and translational research. RESULTS A total of 24 LLMs, published or in preprint between 2022 and 2025, were selected for review. In single-cell transcriptomics, LLMs have primarily been used for cell type annotation, batch integration, and drug-response prediction. In spatial transcriptomics, LLMs support multislide and multimodal spatial data integration, gene expression imputation, niche and region label prediction, spatial domain identification, cell-cell communication inference, and marker gene detection. In computational pathology, LLMs have been applied to cancer subtyping, detection of rare malignancies, genomic mutation prediction, image segmentation, as well as cross-modal retrieval. Despite these advances, many models remain underoptimized for cancer-specific applications, highlighting the need for domain-specific fine-tuning and scalable adaptation strategies. CONCLUSION LLMs have the potential to significantly advance cancer research by providing scalable and effective tools for analyzing and interpreting single-cell, spatial transcriptomic, and pathology data. Future efforts should prioritize tailoring these models to cancer-specific contexts to enhance their utility in uncovering disease mechanisms, identifying biomarkers, and informing therapeutic strategies.

Year:

2025

Background Atherothrombosis, the main event leading to acute coronary syndrome (ACS), is strongly linked to disturbed blood flow (d-flow) regions. Although the involvement of the Hippo pathway and its kinases Large Tumor Suppressor Kinase 1and 2 (LATS 1 and 2) in mechanical stress responses is known, the mechanisms by which d-flow simultaneously induces senescence, proliferation, and atherothrombosis remain unclear. Methods The role of endothelial cells (EC)-specific LATS1/2 was examined using EC specific knock-out (EKO) mice in a partial left carotid ligation (PLCL) model. Plaque spatial multi-omics analysis was performed by integrating imaging mass cytometry, sequential immunofluorescence (COMET™), and spatial metabolomics at the single-cell level in human and mouse atherosclerotic plaques. Results In tamoxifen-inducible Lats1 homo( -/- ) / Lats2 homo( -/- ) EC-specific knockout (EKO) mice, deletion of LATS1/2 induced by tamoxifen led to fatal outcomes, characterized by severe systemic edema and markedly increased vascular permeability. In contrast, Lats1 het(+ /- ) / Lats2 homo( -/- ) -EKO mice survived and developed atherothrombotic plaques exhibiting neovascularization even without further additional dietary or genetic intervention. Spatial proteomics analysis revealed that LATS1/2 depletion in ECs triggered a senescence-associated stemness (SAS) phenotype, primarily driven by CD38 upregulation. Complementary spatial metabolomics profiling demonstrated a significant increase in sulfite and taurine within LATS1/2-deficient plaques, indicating lowered sulfite oxidase (SUOX) activity. Mechanistically, CD38 upregulation was found to suppress SUOX expression, induce the reverse mode of mitochondrial complex V, and increase succinate dehydrogenase (SDH) activity along with ATP consumption. Paradoxically, despite ATP depletion, this metabolic disturbance enhanced glutamate metabolism and the tricarboxylic acid (TCA) cycle, sustaining EC proliferation under energetically stressed conditions. The combined effect of LATS1/2 deletion and CD38 activation established a unique EC phenotype defined by increased SAS, leading to proliferation, senescence, and eventual cell death. These pathological processes culminated in the formation of atherothrombotic plaques, which were attenuated by inhibition of CD38. Notably, a similar phenotype—marked by metabolically active ECs—was observed in human atherothrombotic plaques, suggesting translational relevance. Conclusion Loss of LATS1/2 in ECs induces SAS state that promotes excessive EC proliferation, senescent cell accumulation, and the development of structurally fragile, leaky neo vessels—hallmarks of atherothrombotic lesions. CD38-mediated SUOX deficiency further amplifies this pathological process by inducing mitochondrial dysfunction, depleting ATP, and triggering compensatory upregulation of glutamate and TCA cycle metabolism. These findings identify a novel LATS1/2–CD38–SUOX axis in ECs that orchestrates SAS-driven atherothrombosis. Targeting CD38 may represent a promising therapeutic strategy to mitigate vascular dysfunction and plaque instability in high-risk ACS patients. Graphical abstract Under normal physiological conditions, LATS1/2 and Lamin A work together to suppress CD38 expression. Lamin A binds directly to the CD38 promoter to repress transcription, and LATS1/2 interact with Lamin A to reinforce this suppression. This collaboration helps maintain low CD38 activity and preserves cellular NAD⁺ levels. However, under disturbed flow (d-flow), both LATS1/2 and Lamin A are downregulated. The loss of this dual repression leads to increased CD38 NADase expression. Elevated CD38 accelerates NAD⁺ consumption, causing NAD⁺ depletion—a hallmark of cellular senescence. Reduced NAD⁺ disrupts key metabolic and stress-response pathways, contributing to the onset of the senescent state. At the same time, CD38 suppresses sulfite oxidase (SUOX), leading to sulfite accumulation and mitochondri

Year:

2025

Artificial intelligence has revolutionized computational biology. Recent developments in omics technologies, including single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST), provide detailed genomic data alongside tissue histology. However, current computational models focus on either omics or image analysis, lacking their integration. To address this, we developed OmiCLIP, a visual-omics foundation model linking hematoxylin and eosin (H&E) images and transcriptomics using tissue patches from Visium data. We transformed transcriptomic data into “sentences” by concatenating top-expressed gene symbols from each patch. We curated a dataset of 2.2 million paired tissue images and transcriptomic data across 32 organs to train OmiCLIP integrating histology and transcriptomics. Building on OmiCLIP, our Loki platform offers five key functions: tissue alignment, annotation via bulk RNA-seq or marker genes, cell type decomposition, image–transcriptomics retrieval, and ST gene expression prediction from H&E images. Compared with 22 state-of-the-art models on 5 simulations, 19 public, and 4 in-house experimental datasets, Loki demonstrated consistent accuracy and robustness.

Year:

2025

Spatial transcriptomics integrates transcriptomics data with histological tissue images, offering deeper insights into cellular organization and molecular functions. However, existing computational platforms mainly focus on genomic analysis, leaving a gap in the seamless integration of genomic and image analysis. To address this, we introduce Thor, a comprehensive computational platform for multi-modal analysis of spatial transcriptomics and histological images. Thor utilizes an anti-shrinking Markov diffusion method to infer single-cell spatial transcriptomes from spot-level data, effectively integrating cell morphology with spatial transcriptomics. The platform features 10 modules designed for cell-level genomic and image analysis. Additionally, we present Mjolnir, a web-based tool for interactive tissue analysis using vivid gigapixel images that display information on histology, gene expression, pathway enrichment, and immune response. Thor's accuracy was validated through simulations and ISH, MERFISH, Xenium, and Stereo-seq datasets. To demonstrate its versatility, we applied Thor for joint genomic-histology analysis across various datasets. In in-house heart failure patient samples, Thor identified a regenerative signature in heart failure, with protein presence confirmed in blood vessels through immunofluorescence staining. Thor also revealed the layered structure of the mouse olfactory bulb, performed unbiased screening of breast cancer hallmarks, elucidated the heterogeneity of immune responses, and annotated fibrotic regions in multiple heart failure zones using a semi-supervised approach. Furthermore, Thor imputed high-resolution spatial transcriptomics data in an in-house bladder cancer sample sequenced using Visium HD, uncovering stronger spatial patterns that align more closely with histology. Bridging the gap between genomic and image analysis in spatial biology, Thor offers a powerful tool for comprehensive cellular and molecular analysis.

Year:

2025

Year:

2024

Exercise changes the tumor microenvironment by remodeling blood vessels and increasing infiltration by cytotoxic immune cells. The mechanisms driving these changes remain unclear. Herein, we demonstrate that exercise normalizes tumor vasculature and upregulates endothelial expression of VCAM1 in YUMMER 1.7 and B16F10 murine models of melanoma but differentially regulates tumor growth, hypoxia, and the immune response. We found that exercise suppressed tumor growth and increased CD8+ T-cell infiltration in YUMMER but not in B16F10 tumors. Single-cell RNA sequencing and flow cytometry revealed exercise modulated the number and phenotype of tumor-infiltrating CD8+ T cells and myeloid cells. Specifically, exercise caused a phenotypic shift in the tumor-associated macrophage population and increased the expression of major histocompatibility complex class II transcripts. We further demonstrated that ERK5 S496A knock-in mice, which are phosphorylation deficient at the S496 residue, ‘mimicked’ the exercise effect when unexercised, yet when exercised, these mice displayed a reversal in the effect of exercise on tumor growth and macrophage polarization compared to wild-type mice. Taken together, our results reveal tumor-specific differences in the immune response to exercise and show that ERK5 signaling via the S496 residue plays a crucial role in exercise-induced tumor microenvironment changes.

Year:

2024

Year:

2023

Collaborators (29)

Paul S. Brookes

Professor

University of Rochester

UNITED STATES
View details

Keith Youker

Assistant Professor

Baylor College of Medicine

UNITED STATES
View details

Emily LaVoy

Associate Professor

University of Houston

UNITED STATES
View details

Keri Schadler

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Li Lai

Assistant Professor, Research Scientist

Houston Methodist Research Institute

UNITED STATES
View details

Pengzhi Zhang

Houston Methodist

UNITED STATES
View details

Riccardo Ballarò

Senior Research Scientist

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Iqbal Mahmud

Assistant Professor

Lamar University

UNITED STATES
View details

Efstratios Koutroumpakis

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jennifer L. McQuade

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Kristopher Brannan

Assistant Professor

Houston Methodist Research Institute

UNITED STATES
View details

Nordin M.J. Hanssen

Amsterdam University Medical Centers

NETHERLANDS
View details

Trisha Roy

Vascular Surgeon-Scientist

Houston Methodist Hospital

UNITED STATES
View details

John Cooke

Professor and Department Chair

Houston Methodist Research Institute

UNITED STATES
View details

Jing Su

Associate Professor

Indiana University School of Medicine

UNITED STATES
View details

Ying H. Shen

Baylor College of Medicine

UNITED STATES
View details

Jun-ichi Abe

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Qin Ma

Vice Chair for Research

Ohio State University

UNITED STATES
View details

Nicolas Palaskas

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

sivareddy kotla

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Qianqian Song

Associate Professor

Purdue University

UNITED STATES
View details

Shengyu Li

Assistant Professor

Houston Methodist

UNITED STATES
View details

Ken Chen

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Masaki Imanishi

Associate Professor

Tokushima University

JAPAN
View details

James F. Martin

Professor

Baylor College of Medicine

UNITED STATES
View details

Anita Deswal

Department Chair

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jared Burks

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Longhou Fang

Associate Professor

Houston Methodist Research Institute

UNITED STATES
View details

Erin Seeley

Mass Spectrometry Imaging Facility Director

University of Texas at Austin

UNITED STATES
View details